Mylan Inc., which provides products to customers in more than 150 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust pipeline; operates the world's third largest active pharmaceutical ingredient manufacturer; and runs a specialty business focused on respiratory and allergy therapies.

Recent Releases

Jan 24, 2012
Mylan to Host Investor Day on Feb. 21, 2012, in New York City

Jan 19, 2012
Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam

View all releases »